ELEV – elevation oncology, inc. - common stock (US:NASDAQ)
Stock Stats
News
Elevation Oncology to Present at the Citizens JMP Life Sciences Conference [Yahoo! Finance]
Elevation Oncology to Present at the Citizens JMP Life Sciences Conference
Elevation Oncology: Mid-2024 EO-3021 Data Could Get Ball Rolling [Seeking Alpha]
Elevation Oncology, Inc. (NASDAQ: ELEV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements [Yahoo! Finance]
Form S-3 Elevation Oncology, Inc.
Form 8-K Elevation Oncology, Inc. For: May 02
Form 10-Q Elevation Oncology, Inc. For: Mar 31
Form ARS Elevation Oncology, Inc. For: Dec 31
Form DEFA14A Elevation Oncology, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.